Search Results

You are looking at 1 - 8 of 8 items for

  • Author or Editor: John N. Meagher x
Clear All Modify Search
Restricted access

Robert B. King and John N. Meagher

Restricted access

George W. Paulson, John N. Meagher and John Burkhart

✓ A rare case of cervical pachymeningitis secondary to mucopolysaccharidosis is reported.

Restricted access

William E. Hunt, John N. Meagher and James E. Barnes

Restricted access

Kenneth H. Abbott, Zinnur H. Rollas and John N. Meagher

Restricted access

William E. Hunt, Bertha A. Bouroncle and John N. Meagher

Restricted access

Studies of Trigeminal Nerve Potentials

In Normal Compared to Abnormal Experimental Preparations

Robert B. King, John N. Meagher and Joseph C. Barnett

Restricted access

Edward J. Kosnik, John N. Meagher and Lowell R. Quenemoen

✓ An unusual case is presented of an intradiploic encephalocele surrounding a cerebrospinal fluid cyst. The relationship of this developmental anomaly to the more commonly encountered midline encephalocele and isolated reports of temporal bone encephaloceles are discussed.

Restricted access

Methylprednisolone and neurological function 1 year after spinal cord injury

Results of the National Acute Spinal Cord Injury Study

Michael B. Bracken, Mary Jo Shepard, Karen G. Hellenbrand, William F. Collins, Linda S. Leo, Daniel F. Freeman, Franklin C. Wagner, Eugene S. Flamm, Howard M. Eisenberg, Joseph H. Goodman, Phanor L. Perot Jr., Barth A. Green, Robert G. Grossman, John N. Meagher, Wise Young, Boguslav Fischer, Guy L. Clifton, William E. Hunt and Nathan Rifkinson

✓ A multi-center double-blind randomized clinical trial was conducted by the National Acute Spinal Cord Injury Study Group to examine the efficacy of high-dose methylprednisolone (1000-mg bolus and 1000 mg daily thereafter for 10 days) compared with that of a standard dose (100-mg bolus and 100 mg daily for 10 days). No significant difference was observed in neurological recovery of motor function, pinprick response, or touch sensation 1 year after injury between the two treatment groups, after adjustment for other potentially confounding factors. Analyses that specifically took into account the patients' total steroid dose and relative weight confirmed the lack of a steroid treatment effect. The case fatality rate was 10.7% during the 1st year after injury, and this was not associated with the steroid treatment protocol or the patient's gender. Deaths did occur significantly more frequently among patients who were completely (15.3%) and partially (8.6%) plegic than among those who were paretic (2.5%, p = 0.0005), and among patients aged 50 years or older (38.6%, p = 0.0001).